Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
Barbara Mora, Hematologist at I.R.C.C.S. Ospedale Maggiore Policlinico, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Happy to share that our collaborative work on the characterization of a recently discovered intronic variant of the erythropoietin gene as a cause of congenital erythrocytosis has been published on the American Journal of Hematology!”
Title: Characterization of a Newly Discovered Non‐Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis
Authors: Barbara Mora, Valentina Bellani, Daniela Pietra, Elena Tagliaferri, Daniele Cattaneo, Oscar Borsani, Alessandra Iurlo, Elisa Fermo, Paola Bianchi, Elisa Rumi, Francesco Passamonti
Read the Full Article on American Journal of Hematology
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 16:24Emerging Advances in Transfusion Medicine from AI to Genomic Blood Typing – ASH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research
-
Feb 20, 2026, 15:49David Smadja: Exploring Endothelial Biology and Hemostasis for Innovation in Patient Care
-
Feb 20, 2026, 15:08Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH